Showing results (51-60 of 67) with videos related to
Sort By:
Pageof 7
Science (New York, N.Y.)|May 1, 2021
Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine doseCatherine J Reynolds, Corinna Pade, Joseph M Gibbons, et al.The Lancet. Infectious Diseases|January 5, 2016
Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional studyJohn G Mattia, Mathew J Vandy, Joyce C Chang, et al.The Lancet. Rheumatology|January 24, 2024
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trialAbhishek Abhishek, Nicholas Peckham, Corinna Pade, et al.Ebiomedicine|October 1, 2022
Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infectionGabriella Captur, James C Moon, Constantin-Cristian Topriceanu, et al.Science (New York, N.Y.)|December 2, 2021
Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variantsCatherine J Reynolds, Joseph M Gibbons, Corinna Pade, et al.Frontiers in Immunology|December 6, 2021
Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 CasesJavier Castillo-Olivares, David A Wells, Matteo Ferrari, et al.Cell Reports. Medicine|April 27, 2022
Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infectionsAneesh Chandran, Joshua Rosenheim, Gayathri Nageswaran, et al.The New England Journal of Medicine|February 16, 2022
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous InfectionVictoria Hall, Sarah Foulkes, Ferdinando Insalata, et al.The Journal of Infection|September 11, 2022
Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN studyAna Atti, Ferdinando Insalata, Edward J Carr, et al.Iscience|June 5, 2023
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infectionMartina Milighetti, Yanchun Peng, Cedric Tan, et al.Pageof 7